This book reviews how the emergence of pharmacogenetics will impact the efficiency of pharmaceutical R&D and improve healthcare decision making and clinical care. It discusses what policies need to change in order for the public to reap the benefits from advances in diagnostic genetic testing.
This site is powered by Keepeek 360, DAM for business.
|Link to this publication:|
|Link to this publication with cover:|
|Link to this page:|